Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics P Chopra, G Sethi, SG Dastidar, A Ray Expert opinion on investigational drugs 19 (1), 27-43, 2010 | 140 | 2010 |
Role of Mycobacterium tuberculosis Ser/Thr Kinase PknF: Implications in Glucose Transport and Cell Division P Deol, R Vohra, AK Saini, A Singh, H Chandra, P Chopra, TK Das, ... Journal of bacteriology 187 (10), 3415-3420, 2005 | 119 | 2005 |
Cytotoxic activity of nucleoside diphosphate kinase secreted from Mycobacterium tuberculosis P Chopra, A Singh, A Koul, S Ramachandran, K Drlica, AK Tyagi, Y Singh European journal of biochemistry 270 (4), 625-634, 2003 | 93 | 2003 |
MK2: a novel molecular target for anti-inflammatory therapy S Duraisamy, M Bajpai, U Bughani, SG Dastidar, A Ray, P Chopra Expert opinion on therapeutic targets 12 (8), 921-936, 2008 | 87 | 2008 |
Phosphoprotein phosphatase of Mycobacterium tuberculosis dephosphorylates serine–threonine kinases PknA and PknB P Chopra, B Singh, R Singh, R Vohra, A Koul, LS Meena, H Koduri, ... Biochemical and biophysical research communications 311 (1), 112-120, 2003 | 87 | 2003 |
Spleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis M Bajpai, P Chopra, SG Dastidar, A Ray Expert opinion on investigational drugs 17 (5), 641-659, 2008 | 84 | 2008 |
Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases P Chopra, V Kanoje, A Semwal, A Ray Expert opinion on investigational drugs 17 (10), 1411-1425, 2008 | 71 | 2008 |
New drug targets for Mycobacterium tuberculosis P Chopra, LS Meena, Y Singh Indian Journal of Medical Research 117, 1-9, 2003 | 68 | 2003 |
Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosis S Chakraborty, P Chopra, A Hak, SG Dastidar, A Ray Expert opinion on investigational drugs 22 (4), 499-515, 2013 | 67 | 2013 |
PknH, a transmembrane Hank's type serine/threonine kinase from Mycobacterium tuberculosis is differentially expressed under stress conditions K Sharma, H Chandra, PK Gupta, M Pathak, A Narayan, LS Meena, ... FEMS microbiology letters 233 (1), 107-113, 2004 | 48 | 2004 |
Recent advances towards identification of new drug targets for Mycobacterium tuberculosis K Sharma, P Chopra, Y Singh Expert Opinion on Therapeutic Targets 8 (2), 79-93, 2004 | 41 | 2004 |
Nucleoside diphosphate kinase of Mycobacterium tuberculosis acts as GTPase‐activating protein for Rho‐GTPases P Chopra, H Koduri, R Singh, A Koul, M Ghildiyal, K Sharma, AK Tyagi, ... FEBS letters 571 (1-3), 212-216, 2004 | 39 | 2004 |
Time-resolved relaxation and fragmentation of polycyclic aromatic hydrocarbons investigated in the ultrafast XUV-IR regime JWL Lee, DS Tikhonov, P Chopra, S Maclot, AL Steber, S Gruet, F Allum, ... Nature Communications 12 (1), 6107, 2021 | 38 | 2021 |
Emerging therapeutic interventions for idiopathic pulmonary fibrosis S Chakraborty, P Chopra, SV Ambi, SG Dastidar, A Ray Expert opinion on investigational drugs 23 (7), 893-910, 2014 | 36 | 2014 |
Nuclear localization and in situ DNA damage by Mycobacterium tuberculosis nucleoside-diphosphate kinase AK Saini, K Maithal, P Chand, S Chowdhury, R Vohra, A Goyal, GP Dubey, ... Journal of Biological Chemistry 279 (48), 50142-50149, 2004 | 34 | 2004 |
Nucleoside diphosphate kinase from Mycobacterium tuberculosis cleaves single strand DNA within the human c-myc promoter in an … P Kumar, A Verma, AK Saini, P Chopra, PK Chakraborti, Y Singh, ... Nucleic acids research 33 (8), 2707-2714, 2005 | 29 | 2005 |
Bioremediation of melanoidin containing digested spentwash from cane-molasses distillery with white rot fungus Coriolus versicolor P Chopra, D Singh, V Verma, AK Puniya Indian J Microbiol 44, 197-200, 2004 | 27 | 2004 |
Cloning and characterization of GTP-binding proteins of Mycobacterium tuberculosis H37Rv LS Meena, P Chopra, RS Bedwal, Y Singh Enzyme and microbial technology 42 (2), 138-144, 2008 | 24 | 2008 |
Biochemical characterization of an S-adenosyl-l-methionine-dependent methyltransferase (Rv0469) of Mycobacterium tuberculosis LS Meena, P Chopra, RA Vishwakarma, Y Singh Biological Chemistry 394 (7), 871-877, 2013 | 23 | 2013 |
Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase P Chopra, O Kulkarni, S Gupta, M Bajpai, V Kanoje, M Banerjee, V Bansal, ... International immunopharmacology 10 (4), 467-473, 2010 | 20 | 2010 |